Nasdaq: KLRS
Kalaris Therapeutics insiders
The officers, directors and 10% owners of Kalaris Therapeutics, Inc. who hold the most stock, valued at the live KLRS price.
$1.35
KLRS today −$20K (−1.46%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their KLRS stock
- $3.8M
- Market value
- $32.1M
- Held by ranked insiders
- 11.7%
Insiders by value of KLRS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Vikas Sinha | See Remarks | 955,365 | $1.3M | 4.01% | 3543rd |
| 2 | Gilead Sciences, Inc. | 10% owner | 723,273 | $976K | 3.04% | Corporate |
| 3 | Morana Jovan-Embiricos | Director | 612,912 | $827K | 2.57% | 3732nd |
| 4 | David Hallal | Director | 311,803 | $421K | 1.31% | 1576th |
| 5 | Ansbert Gadicke | Director | 182,560 | $246K | 0.77% | 13301st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Kalaris Therapeutics; see each profile for the filing.